HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.

Abstract
The RNA-binding protein Tristetraprolin (TTP, ZFP36) functions as a tumor suppressor that impairs the development and disables the maintenance of MYC-driven lymphoma. In addition, other human cancers expressed reduced levels of TTP, suggesting that it may function as a tumor suppressor in several malignancies. To identify genes that may be associated with TTP tumor suppressor functions in human cancer, we analyzed The Cancer Genome Atlas (TCGA) breast cancer, lung adenocarcinoma, lung squamous cell carcinoma, and colon adenocarcinoma datasets. These analyses defined a signature of 50 genes differentially regulated between high and low TTP-expressing tumors. Notably, patients with low TTP-expressing breast cancer and lung adenocarcinoma had decreased survival rates and more aggressive tumors with increased necrosis. In addition, analysis across non-TCGA tumor gene expression databases identified a broad spectrum of human cancers having similarities with the TTP-low tumor gene signature, including pancreatic, bladder, and prostate cancer. TTP has documented roles in regulating mRNAs encoding inflammatory proteins, and pathway analysis identified several inflammatory pathways that are altered in tumors with low TTP expression. Surprisingly, the TTP-low tumor gene signature includes a core component of 20 under-expressed CREB target genes, suggesting that the regulation of CREB activity may be related to the tumor suppressor function of TTP. Thus, reduced levels of TTP are a potential biomarker for human cancers with poor outcome, and targeting the CREB pathway may be a therapeutic route for treating aggressive TTP-low tumors.
AuthorsMohammad Fallahi, Antonio L Amelio, John L Cleveland, Robert J Rounbehler
JournalPloS one (PLoS One) Vol. 9 Issue 12 Pg. e115517 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25541715 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclic AMP Response Element-Binding Protein
  • Tristetraprolin
  • ZFP36 protein, human
Topics
  • Breast Neoplasms (diagnosis, genetics, metabolism)
  • Carcinoma (diagnosis, genetics, metabolism)
  • Colonic Neoplasms (diagnosis, genetics, metabolism)
  • Cyclic AMP Response Element-Binding Protein (genetics, metabolism)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms (diagnosis, genetics, metabolism)
  • Prognosis
  • Transcriptome
  • Tristetraprolin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: